![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/4d065d23-33ad-42b7-bfbc-8a244219872f/dom14496-fig-0004-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![Dr. Hector P. Garcia, founder of the American G.I. Forum, received the Presidential Medal of Freedom, Dr. Hector P. Garcia, founder of the American G.I. Forum, received the Presidential Medal of Freedom,](https://media.defense.gov/2007/Mar/14/2001087179/1088/820/0/062622-H-YGR38-240.jpg)
Dr. Hector P. Garcia, founder of the American G.I. Forum, received the Presidential Medal of Freedom,
![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/cef7eacf-1f50-4531-9c5d-b839fae38f91/dom14496-fig-0001-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment](https://pub.mdpi-res.com/life/life-12-00029/article_deploy/html/images/life-12-00029-g001.png?1640431486)
Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment
![Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0079610711000812-gr2.jpg)
Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect
![Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/852ca66060ffdba66beb14e27e19fbc2a63a970f/3-Figure3-1.png)
Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar
![The release of GIP is triggered in the upper small intestine by rapidly... | Download Scientific Diagram The release of GIP is triggered in the upper small intestine by rapidly... | Download Scientific Diagram](https://www.researchgate.net/publication/324048251/figure/fig4/AS:868751654273048@1584137943929/The-release-of-GIP-is-triggered-in-the-upper-small-intestine-by-rapidly-absorbed-high-GI.png)
The release of GIP is triggered in the upper small intestine by rapidly... | Download Scientific Diagram
Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species Matter | Molecular Pharmaceutics
![IJMS | Free Full-Text | GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review IJMS | Free Full-Text | GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review](https://www.mdpi.com/ijms/ijms-21-01509/article_deploy/html/images/ijms-21-01509-g001.png)
IJMS | Free Full-Text | GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
![Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ... Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ...](https://www.mdpi.com/biology/biology-11-00288/article_deploy/html/images/biology-11-00288-g001.png)
Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ...
![Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/852ca66060ffdba66beb14e27e19fbc2a63a970f/3-Figure2-1.png)